Trials / Completed
CompletedNCT07424313
The Low FODMAP Diet in Individuals With Small Intestinal Bacterial Overgrowth (SIBO)
Assessment of the Impact of the Low FODMAP Diet on Gastrointestinal Symptoms and Nutritional Status in People With Small Intestinal Bacterial Overgrowth (SIBO)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 51 (actual)
- Sponsor
- Warsaw University of Life Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to assess the impact of a low FODMAP diet (LFD) on gastrointestinal symptoms and nutritional status in individuals diagnosed with small intestinal bacterial overgrowth (SIBO). Participants were randomly assigned to either an intervention group or a control group following completion of antibiotic therapy. The intervention group followed a LFD, while the control group followed a normal diet, in accordance with the principles of rational nutrition. Gastrointestinal symptoms, nutritional status, and quality of life were assessed using questionnaires, dietary records, anthropometric measurements, and blood biochemical parameters.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Low FODMAP Diet | Following a low FODMAP diet (elimination and reintroduction phases for 4 and 8 weeks, respectively, for a total of 12 weeks) |
| OTHER | Healthy Eating Diet | Applying recommendations consistent with proper nutrition principles, with particular focus on breaks between meals and the principle of mindful eating |
Timeline
- Start date
- 2024-02-08
- Primary completion
- 2025-09-18
- Completion
- 2026-01-15
- First posted
- 2026-02-20
- Last updated
- 2026-02-24
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT07424313. Inclusion in this directory is not an endorsement.